Tela Selling And Marketing Expenses from 2010 to 2024
| TELA Stock | USD 2.94 0.07 2.33% |
Selling And Marketing Expenses | First Reported 2018-09-30 | Previous Quarter 16.7 M | Current Value 16.5 M | Quarterly Volatility 4.8 M |
Check Tela Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tela Bio's main balance sheet or income statement drivers, such as Interest Income of 2.6 M, Depreciation And Amortization of 850.9 K or Interest Expense of 4.1 M, as well as many indicators such as Price To Sales Ratio of 2.46, Dividend Yield of 0.0 or PTB Ratio of 4.3. Tela financial statements analysis is a perfect complement when working with Tela Bio Valuation or Volatility modules.
Tela | Selling And Marketing Expenses |
Latest Tela Bio's Selling And Marketing Expenses Growth Pattern
Below is the plot of the Selling And Marketing Expenses of Tela Bio over the last few years. It is Tela Bio's Selling And Marketing Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tela Bio's overall financial position and show how it may be relating to other accounts over time.
| Selling And Marketing Expenses | 10 Years Trend |
|
Selling And Marketing Expenses |
| Timeline |
Tela Selling And Marketing Expenses Regression Statistics
| Arithmetic Mean | 19,071,737 | |
| Geometric Mean | 14,945,622 | |
| Coefficient Of Variation | 81.28 | |
| Mean Deviation | 11,908,716 | |
| Median | 8,712,000 | |
| Standard Deviation | 15,501,292 | |
| Sample Variance | 240.3T | |
| Range | 51M | |
| R-Value | 0.80 | |
| Mean Square Error | 93T | |
| R-Squared | 0.64 | |
| Significance | 0.0003 | |
| Slope | 2,774,048 | |
| Total Sum of Squares | 3364.1T |
Tela Selling And Marketing Expenses History
About Tela Bio Financial Statements
Tela Bio stakeholders use historical fundamental indicators, such as Tela Bio's Selling And Marketing Expenses, to determine how well the company is positioned to perform in the future. Although Tela Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Tela Bio's assets and liabilities are reflected in the revenues and expenses on Tela Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Tela Bio. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 59.7 M | 30.6 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Tela Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tela Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tela Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tela Bio Stock:Check out the analysis of Tela Bio Correlation against competitors. For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tela Bio. If investors know Tela will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tela Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.69) | Revenue Per Share 2.789 | Quarterly Revenue Growth 0.259 | Return On Assets (0.41) | Return On Equity (3.42) |
The market value of Tela Bio is measured differently than its book value, which is the value of Tela that is recorded on the company's balance sheet. Investors also form their own opinion of Tela Bio's value that differs from its market value or its book value, called intrinsic value, which is Tela Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tela Bio's market value can be influenced by many factors that don't directly affect Tela Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tela Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tela Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tela Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.